Paxlovid substantially reduced risk of hospitalization, death during Omicron wave
Nirmatrelvir–ritonavir (Paxlovid) significantly reduced the likelihood of hospitalization or death from COVID-19 in people at risk of severe illness, according to new research in Canadian […]
Read more